{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:57:29Z","timestamp":1788973049142,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007957","name":"Chongqing Municipal Education Commission","doi-asserted-by":"publisher","award":["CYB23290"],"award-info":[{"award-number":["CYB23290"]}],"id":[{"id":"10.13039\/501100007957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.intimp.2025.115973","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T09:47:06Z","timestamp":1764928026000},"page":"115973","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["ACAT1 inhibitor Avasimibe suppresses osteoclastogenesis and alleviates ovariectomy-induced bone loss via CKB\/PI3K-AKT signaling"],"prefix":"10.1016","volume":"169","author":[{"given":"Xu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaoqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sizhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongwei","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.115973_bb0005","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","article-title":"Osteoporosis: now and the future","volume":"377","author":"Rachner","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2025.115973_bb0010","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician\u2019s guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff","year":"2022","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.intimp.2025.115973_bb0015","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(15)61120-5","article-title":"Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-switch study): extension of a randomised controlled trial","volume":"386","author":"Leder","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2025.115973_bb0020","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.2174\/1381612823666170516124659","article-title":"Pharmacological treatment of bone loss","volume":"23","author":"Pang","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.intimp.2025.115973_bb0025","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/sj.bjc.6604382","article-title":"Risks and benefits of bisphosphonates","volume":"98","author":"Coleman","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.intimp.2025.115973_bb0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12325-021-01936-y","article-title":"Denosumab in the treatment of osteoporosis: 10 years later: a narrative review","volume":"39","author":"Kendler","year":"2022","journal-title":"Adv. Ther."},{"key":"10.1016\/j.intimp.2025.115973_bb0035","doi-asserted-by":"crossref","first-page":"947","DOI":"10.4103\/2230-8210.117209","article-title":"Raised CA19.9 and hepatic space occupying lesion after teriparatide therapy in a case of polyostotic fibrous dysplasia","volume":"17","author":"Pandit","year":"2013","journal-title":"Indian J Endocr Metab"},{"key":"10.1016\/j.intimp.2025.115973_bb0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2152\/jmi.62.93","article-title":"Transient severe hypotension with once-weekly subcutaneous injection of teriparatide in osteoporotic patient: a case report and insight for the drug interaction between hypotensive agents and teriparatide","volume":"62","author":"Enishi","year":"2015","journal-title":"J. Med. Investig."},{"key":"10.1016\/j.intimp.2025.115973_bb0045","article-title":"Bone-targeted exosomes: strategies and applications","volume":"12","author":"Wang","year":"2023","journal-title":"Adv Healthcare Materials"},{"key":"10.1016\/j.intimp.2025.115973_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jb\/mvv112","article-title":"The role of osteoclast differentiation and function in skeletal homeostasis","volume":"159","author":"Ikeda","year":"2016","journal-title":"J. Biochem."},{"key":"10.1016\/j.intimp.2025.115973_bb0055","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jsbmb.2013.09.008","article-title":"Prevention and treatment of postmenopausal osteoporosis","volume":"142","author":"Tella","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.intimp.2025.115973_bb0060","doi-asserted-by":"crossref","first-page":"16568","DOI":"10.1073\/pnas.1308755110","article-title":"HIF1\u03b1 is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis","volume":"110","author":"Miyauchi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2025.115973_bb0065","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1471-2458-10-230","article-title":"Incidence and mortality of hip fracture among the elderly population in South Korea: a population-based study using the National Health Insurance claims data","volume":"10","author":"Kang","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1016\/j.intimp.2025.115973_bb0070","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1210\/endo-123-5-2600","article-title":"Osteoblastic cells are involved in osteoclast formation","volume":"123","author":"Takahashi","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.intimp.2025.115973_bb0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.intimp.2025.115973_bb0080","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1038\/sj.cdd.4401882","article-title":"Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-jB transactivation by RANKL","volume":"13","author":"Huang","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2025.115973_bb0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.0105-2896.2005.00336.x","article-title":"Osteoclast precursors, RANKL\/RANK, and immunology","volume":"208","author":"Xing","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2025.115973_bb0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000112634","article-title":"Statin Therapy Alone and in Combination with an Acyl-CoA:Cholesterol O-Acyltransferase Inhibitor on Experimental Atherosclerosis","volume":"36","author":"Worthley","year":"2007","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"10.1016\/j.intimp.2025.115973_bb0095","article-title":"Avasimibe dampens cholangiocarcinoma progression by inhibiting FoxM1-AKR1C1 signaling","volume":"11","author":"Gao","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2025.115973_bb0100","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/s12935-021-02175-5","article-title":"The cholesterol esterification inhibitor avasimibe suppresses tumour proliferation and metastasis via the E2F-1 signalling pathway in prostate cancer","volume":"21","author":"Xiong","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"3","key":"10.1016\/j.intimp.2025.115973_bb0105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cmet.2014.01.019","article-title":"Cholesteryl ester accumulation induced by PTEN loss and PI3K\/AKT activation underlies human prostate cancer aggressiveness","volume":"19","author":"Yue","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2025.115973_bb0110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4049\/jimmunol.1101254","article-title":"Akt induces osteoclast differentiation through regulating the GSK3b\/NFATc1 signaling Cascade","volume":"188","author":"Moon","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.115973_bb0115","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1038\/s12276-023-01085-y","article-title":"CircFam190a: a critical positive regulator of osteoclast differentiation via enhancement of the AKT1\/HSP90\u03b2 complex","volume":"55","author":"Chen","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2025.115973_bb0120","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.2147\/DDDT.S328238","article-title":"Oroxin B attenuates Ovariectomy-induced bone loss by suppressing osteoclast formation and activity","volume":"15","author":"Huang","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.intimp.2025.115973_bb0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S8756-3282(01)00657-3","article-title":"The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation","volume":"30","author":"Lee","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.intimp.2025.115973_bb0130","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/BF00318056","article-title":"Wortmannin, a potent inhibitor of phosphatidylinositol 3-kinase, inhibits osteoclastic bone resorption in vitro","volume":"56","author":"Hall","year":"1995","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.intimp.2025.115973_bb0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bone.2003.09.005","article-title":"The expanding role of PI3-kinase in bone","volume":"34","author":"Golden","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.intimp.2025.115973_bb0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/bj2810021","article-title":"Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the \u2018phosphocreatine circuit\u2019 for cellular energy homeostasis","volume":"281","author":"Wallimann","year":"1992","journal-title":"Biochem. J."},{"key":"10.1016\/j.intimp.2025.115973_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.115971","article-title":"Cytochalasin Q exerts anti-melanoma effect by inhibiting creatine kinase B","volume":"441","author":"Lu","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2025.115973_bb0150","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0531-5565(03)00069-X","article-title":"Molecular mechanisms underlying osteoclast formation and activation","volume":"38","author":"Troen","year":"2003","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.intimp.2025.115973_bb0155","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in Cancer after treatment with bisphosphonates: incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"JCO"},{"key":"10.1016\/j.intimp.2025.115973_bb0160","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/jbmr.4472","article-title":"Risk of osteonecrosis of the jaw under Denosumab compared to bisphosphonates in patients with osteoporosis","volume":"37","author":"Everts-Graber","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.intimp.2025.115973_bb0165","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/med.2610140302","article-title":"ACAT inhibitors as antiatherosclerotic agents: compounds and mechanisms","volume":"14","author":"Matsuda","year":"1994","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.intimp.2025.115973_bb0170","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cca.2013.06.006","article-title":"Foam cells in atherosclerosis","volume":"424","author":"Yu","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.intimp.2025.115973_bb0175","article-title":"Targeting ACAT1 in cancer: from threat to treatment","volume":"14","author":"Sun","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2025.115973_bb0180","doi-asserted-by":"crossref","first-page":"233","DOI":"10.11005\/jbm.2014.21.4.233","article-title":"Regulation of NFATc1 in osteoclast differentiation","volume":"21","author":"Kim","year":"2014","journal-title":"J Bone Metab"},{"key":"10.1016\/j.intimp.2025.115973_bb0185","doi-asserted-by":"crossref","first-page":"706","DOI":"10.14348\/molcells.2017.0225","article-title":"Current understanding of RANK signaling in osteoclast differentiation and maturation","volume":"40","author":"Park","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.intimp.2025.115973_bb0190","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ijdevneu.2010.06.001","article-title":"Involvement of the PI3K\/AKT pathway in ATP-induced proliferation of developing retinal cells in culture","volume":"28","author":"Ornelas","year":"2010","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.intimp.2025.115973_bb0195","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aad7885","article-title":"Following the trail of lipids: signals initiated by PI3K function at multiple cellular membranes","volume":"9","author":"Naguib","year":"2016","journal-title":"Sci. Signal."},{"issue":"6527","key":"10.1016\/j.intimp.2025.115973_bb0200","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.abb2683","article-title":"Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity","volume":"371","author":"Xu","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.intimp.2025.115973_bb0205","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cmet.2014.09.013","article-title":"AMPK\u2014sensing energy while talking to other signaling pathways","volume":"20","author":"Hardie","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2025.115973_bb0210","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/bj20020703","article-title":"A homologue of AMP-activated protein kinase in Drosophila melanogaster is sensitive to AMP and is activated by ATP depletion","volume":"367","author":"Pan","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.intimp.2025.115973_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154561","article-title":"Pterostilbene alleviated NAFLD via AMPK\/mTOR signaling pathways and autophagy by promoting Nrf2","volume":"109","author":"Shen","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2025.115973_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2024.105919","article-title":"Isobavachin induces autophagy-mediated cytotoxicity in AML12 cells via AMPK and PI3K\/Akt\/mTOR pathways","volume":"100","author":"Xia","year":"2024","journal-title":"Toxicol. in Vitro"},{"issue":"21","key":"10.1016\/j.intimp.2025.115973_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113578","article-title":"SIRT1 promotes host protective immunity against toxoplasma gondii by controlling the FoxO-autophagy Axis via the AMPK and PI3K\/AKT Signalling pathways","volume":"23","author":"Lee","year":"2022","journal-title":"Int. J. Mol. Sci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925019617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925019617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:37:27Z","timestamp":1768473447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925019617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":45,"alternative-id":["S1567576925019617"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115973","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ACAT1 inhibitor Avasimibe suppresses osteoclastogenesis and alleviates ovariectomy-induced bone loss via CKB\/PI3K-AKT signaling","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115973","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115973"}}